Antistaphylococcal Activity of Rifampin-Bonded Gelatin-Impregnated Dacron Grafts

Vivian Gahtan, Glenn E. Esses, Dennis F. Bandyk, Rex T. Nelson, Elisabeth Dupont, Joseph L Mills

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The affinity of rifampin to bond to Dacron permits implantation of a vascular prosthesis with anti-staphylococcal bioactivity. The performance of rifampin-bonded Dacron grafts was evaluated in vitro and in vivo to develop a bonding technique with optimal graft bioactivity which was then used for in situ reconstruction of a biofilm graft infection. In vitro bioactivity was measured at 24-hr intervals for three types of Dacron prostheses (plain, gelatin, and collagen-impregnated) exposed to rifampin at varied concentrations and immersion times. Gelatin-impregnated grafts demonstrated superior bioactivity (P < 0.05). Rifampin concentration and graft type had a greater effect on bioactivity than immersion time (P < 0.01). Gelatin-impregnated grafts immersed in a 60 mg/ml rifampin solution for 15 rain produced optimum bioactivity. Six grafts prepared in this fashion were used to replace the canine aorta. The level and duration of in vivo antistaphylococcal activity to Staphylococcus aureus and Staphylococcus epidermidis were less (P < 0.05) than those measured in vitro, but rifampin levels exceeded the study strain maximum inhibitory concentration for up to 48 hr. In a canine model, the rifampin-bonded gelatin-impregnated (N = 14) or nonbonded control (N = 10) grafts were used as in situ replacement for an established aortic graft infection caused by S. epidermidis. Replacement with a rifampin-bonded graft resulted in successful anatomic healing of perigraft and anastomotic tissue. Persistent biofilm colonization was confirmed in 8 of 10 controls versus 4 of 14 rifampin-bonded grafts (P < 0.02). Rifampin-bonding to Dacron grafts by passive absorption was practical and produced a minimum of 48 hr duration of in vivo antistaphylococcal activity. This level was sufficient to reduce prosthesis colonization when used for in situ replacement of a low-grade graft infection.

Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalJournal of Surgical Research
Volume58
Issue number1
DOIs
StatePublished - Jan 1995

Fingerprint

Polyethylene Terephthalates
Gelatin
Rifampin
Transplants
Staphylococcus epidermidis
Immersion
Biofilms
Blood Vessel Prosthesis Implantation
Prostheses and Implants
Canidae
Infection
Rain
Aorta
Staphylococcus aureus
Collagen

ASJC Scopus subject areas

  • Surgery

Cite this

Antistaphylococcal Activity of Rifampin-Bonded Gelatin-Impregnated Dacron Grafts. / Gahtan, Vivian; Esses, Glenn E.; Bandyk, Dennis F.; Nelson, Rex T.; Dupont, Elisabeth; Mills, Joseph L.

In: Journal of Surgical Research, Vol. 58, No. 1, 01.1995, p. 105-110.

Research output: Contribution to journalArticle

Gahtan, Vivian ; Esses, Glenn E. ; Bandyk, Dennis F. ; Nelson, Rex T. ; Dupont, Elisabeth ; Mills, Joseph L. / Antistaphylococcal Activity of Rifampin-Bonded Gelatin-Impregnated Dacron Grafts. In: Journal of Surgical Research. 1995 ; Vol. 58, No. 1. pp. 105-110.
@article{e4507cc894e84fe08e78e38a7fd7b04d,
title = "Antistaphylococcal Activity of Rifampin-Bonded Gelatin-Impregnated Dacron Grafts",
abstract = "The affinity of rifampin to bond to Dacron permits implantation of a vascular prosthesis with anti-staphylococcal bioactivity. The performance of rifampin-bonded Dacron grafts was evaluated in vitro and in vivo to develop a bonding technique with optimal graft bioactivity which was then used for in situ reconstruction of a biofilm graft infection. In vitro bioactivity was measured at 24-hr intervals for three types of Dacron prostheses (plain, gelatin, and collagen-impregnated) exposed to rifampin at varied concentrations and immersion times. Gelatin-impregnated grafts demonstrated superior bioactivity (P < 0.05). Rifampin concentration and graft type had a greater effect on bioactivity than immersion time (P < 0.01). Gelatin-impregnated grafts immersed in a 60 mg/ml rifampin solution for 15 rain produced optimum bioactivity. Six grafts prepared in this fashion were used to replace the canine aorta. The level and duration of in vivo antistaphylococcal activity to Staphylococcus aureus and Staphylococcus epidermidis were less (P < 0.05) than those measured in vitro, but rifampin levels exceeded the study strain maximum inhibitory concentration for up to 48 hr. In a canine model, the rifampin-bonded gelatin-impregnated (N = 14) or nonbonded control (N = 10) grafts were used as in situ replacement for an established aortic graft infection caused by S. epidermidis. Replacement with a rifampin-bonded graft resulted in successful anatomic healing of perigraft and anastomotic tissue. Persistent biofilm colonization was confirmed in 8 of 10 controls versus 4 of 14 rifampin-bonded grafts (P < 0.02). Rifampin-bonding to Dacron grafts by passive absorption was practical and produced a minimum of 48 hr duration of in vivo antistaphylococcal activity. This level was sufficient to reduce prosthesis colonization when used for in situ replacement of a low-grade graft infection.",
author = "Vivian Gahtan and Esses, {Glenn E.} and Bandyk, {Dennis F.} and Nelson, {Rex T.} and Elisabeth Dupont and Mills, {Joseph L}",
year = "1995",
month = "1",
doi = "10.1006/jsre.1995.1017",
language = "English (US)",
volume = "58",
pages = "105--110",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Antistaphylococcal Activity of Rifampin-Bonded Gelatin-Impregnated Dacron Grafts

AU - Gahtan, Vivian

AU - Esses, Glenn E.

AU - Bandyk, Dennis F.

AU - Nelson, Rex T.

AU - Dupont, Elisabeth

AU - Mills, Joseph L

PY - 1995/1

Y1 - 1995/1

N2 - The affinity of rifampin to bond to Dacron permits implantation of a vascular prosthesis with anti-staphylococcal bioactivity. The performance of rifampin-bonded Dacron grafts was evaluated in vitro and in vivo to develop a bonding technique with optimal graft bioactivity which was then used for in situ reconstruction of a biofilm graft infection. In vitro bioactivity was measured at 24-hr intervals for three types of Dacron prostheses (plain, gelatin, and collagen-impregnated) exposed to rifampin at varied concentrations and immersion times. Gelatin-impregnated grafts demonstrated superior bioactivity (P < 0.05). Rifampin concentration and graft type had a greater effect on bioactivity than immersion time (P < 0.01). Gelatin-impregnated grafts immersed in a 60 mg/ml rifampin solution for 15 rain produced optimum bioactivity. Six grafts prepared in this fashion were used to replace the canine aorta. The level and duration of in vivo antistaphylococcal activity to Staphylococcus aureus and Staphylococcus epidermidis were less (P < 0.05) than those measured in vitro, but rifampin levels exceeded the study strain maximum inhibitory concentration for up to 48 hr. In a canine model, the rifampin-bonded gelatin-impregnated (N = 14) or nonbonded control (N = 10) grafts were used as in situ replacement for an established aortic graft infection caused by S. epidermidis. Replacement with a rifampin-bonded graft resulted in successful anatomic healing of perigraft and anastomotic tissue. Persistent biofilm colonization was confirmed in 8 of 10 controls versus 4 of 14 rifampin-bonded grafts (P < 0.02). Rifampin-bonding to Dacron grafts by passive absorption was practical and produced a minimum of 48 hr duration of in vivo antistaphylococcal activity. This level was sufficient to reduce prosthesis colonization when used for in situ replacement of a low-grade graft infection.

AB - The affinity of rifampin to bond to Dacron permits implantation of a vascular prosthesis with anti-staphylococcal bioactivity. The performance of rifampin-bonded Dacron grafts was evaluated in vitro and in vivo to develop a bonding technique with optimal graft bioactivity which was then used for in situ reconstruction of a biofilm graft infection. In vitro bioactivity was measured at 24-hr intervals for three types of Dacron prostheses (plain, gelatin, and collagen-impregnated) exposed to rifampin at varied concentrations and immersion times. Gelatin-impregnated grafts demonstrated superior bioactivity (P < 0.05). Rifampin concentration and graft type had a greater effect on bioactivity than immersion time (P < 0.01). Gelatin-impregnated grafts immersed in a 60 mg/ml rifampin solution for 15 rain produced optimum bioactivity. Six grafts prepared in this fashion were used to replace the canine aorta. The level and duration of in vivo antistaphylococcal activity to Staphylococcus aureus and Staphylococcus epidermidis were less (P < 0.05) than those measured in vitro, but rifampin levels exceeded the study strain maximum inhibitory concentration for up to 48 hr. In a canine model, the rifampin-bonded gelatin-impregnated (N = 14) or nonbonded control (N = 10) grafts were used as in situ replacement for an established aortic graft infection caused by S. epidermidis. Replacement with a rifampin-bonded graft resulted in successful anatomic healing of perigraft and anastomotic tissue. Persistent biofilm colonization was confirmed in 8 of 10 controls versus 4 of 14 rifampin-bonded grafts (P < 0.02). Rifampin-bonding to Dacron grafts by passive absorption was practical and produced a minimum of 48 hr duration of in vivo antistaphylococcal activity. This level was sufficient to reduce prosthesis colonization when used for in situ replacement of a low-grade graft infection.

UR - http://www.scopus.com/inward/record.url?scp=0028795710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028795710&partnerID=8YFLogxK

U2 - 10.1006/jsre.1995.1017

DO - 10.1006/jsre.1995.1017

M3 - Article

C2 - 7830398

AN - SCOPUS:0028795710

VL - 58

SP - 105

EP - 110

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -